Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure

Chemoreflex control of sympathetic nerve activity is exaggerated in heart failure (HF) patients. However, the vascular implications of the augmented sympathetic activity during chemoreceptor activation in patients with HF are unknown. We tested the hypothesis that the muscle blood flow responses dur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American Journal of Physiology: Cell Physiology 2007-07, Vol.293 (1), p.H846-H852
Hauptverfasser: Di Vanna, Andrea, Braga, Ana Maria FW, Laterza, Mateus C, Ueno, Linda M, Rondon, Maria Urbana PB, Barretto, Antonio CP, Middlekauff, Holly R, Negrao, Carlos E
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H852
container_issue 1
container_start_page H846
container_title American Journal of Physiology: Cell Physiology
container_volume 293
creator Di Vanna, Andrea
Braga, Ana Maria FW
Laterza, Mateus C
Ueno, Linda M
Rondon, Maria Urbana PB
Barretto, Antonio CP
Middlekauff, Holly R
Negrao, Carlos E
description Chemoreflex control of sympathetic nerve activity is exaggerated in heart failure (HF) patients. However, the vascular implications of the augmented sympathetic activity during chemoreceptor activation in patients with HF are unknown. We tested the hypothesis that the muscle blood flow responses during peripheral and central chemoreflex stimulation would be blunted in patients with HF. Sixteen patients with HF (49 plus or minus 3 years old, Functional Class II-III, New York Heart Association) and 11 age-paired normal controls were studied. The peripheral chemoreflex control was evaluated by inhalation of 10% O sub(2) and 90% N sub(2) for 3 min. The central chemoreflex control was evaluated by inhalation of 7% CO sub(2) and 93% O sub(2) for 3 min. Muscle sympathetic nerve activity (MSNA) was directly evaluated by microneurography. Forearm blood flow was evaluated by venous occlusion plethysmography. Baseline MSNA were significantly greater in HF patients (33 plus or minus 3 vs. 20 plus or minus 2 bursts/min, P = 0.001). Forearm vascular conductance (FVC) was not different between the groups. During hypoxia, the increase in MSNA was significantly greater in HF patients than in normal controls (9.0 plus or minus 1.6 vs. 0.8 plus or minus 2.0 bursts/min, P = 0.001). The increase in FVC was significantly lower in HF patients (0.00 plus or minus 0.10 vs. 0.76 plus or minus 0.25 units, P = 0.001). During hypercapnia, MSNA responses were significantly greater in HF patients than in normal controls (13.9 plus or minus 3.2 vs. 2.1 plus or minus 1.9 bursts/min, P = 0.001). FVC responses were significantly lower in HF patients (-0.29 plus or minus 0.10 vs. 0.37 plus or minus 0.18 units, P = 0.001). In conclusion, muscle vasodilatation during peripheral and central chemoreceptor stimulation is blunted in HF patients. This vascular response seems to be explained, at least in part, by the exaggerated MSNA responses during hypoxia and hypercapnia.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_19731357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19731357</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_197313573</originalsourceid><addsrcrecordid>eNqNyk0KwjAQQOEgCtafO8zKXaFpbKVbRfEAbqWEdmojaVIzE72-gh7A1XuLbyISWeR5KotSTUWSqVKlpdyquVgQ3bMs2-ZllYjr3kbH2MIQqbEIT02-NVazZuMdtDEYd4Omx8EHbHBkH4DYDNF-gXEwfg4dE7wM99CjDgydNjYGXIlZpy3h-tel2JyOl8M5HYN_RCSuB0MNWqsd-ki1rHZKqmKn_oZv2n5J1g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19731357</pqid></control><display><type>article</type><title>Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure</title><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Di Vanna, Andrea ; Braga, Ana Maria FW ; Laterza, Mateus C ; Ueno, Linda M ; Rondon, Maria Urbana PB ; Barretto, Antonio CP ; Middlekauff, Holly R ; Negrao, Carlos E</creator><creatorcontrib>Di Vanna, Andrea ; Braga, Ana Maria FW ; Laterza, Mateus C ; Ueno, Linda M ; Rondon, Maria Urbana PB ; Barretto, Antonio CP ; Middlekauff, Holly R ; Negrao, Carlos E</creatorcontrib><description>Chemoreflex control of sympathetic nerve activity is exaggerated in heart failure (HF) patients. However, the vascular implications of the augmented sympathetic activity during chemoreceptor activation in patients with HF are unknown. We tested the hypothesis that the muscle blood flow responses during peripheral and central chemoreflex stimulation would be blunted in patients with HF. Sixteen patients with HF (49 plus or minus 3 years old, Functional Class II-III, New York Heart Association) and 11 age-paired normal controls were studied. The peripheral chemoreflex control was evaluated by inhalation of 10% O sub(2) and 90% N sub(2) for 3 min. The central chemoreflex control was evaluated by inhalation of 7% CO sub(2) and 93% O sub(2) for 3 min. Muscle sympathetic nerve activity (MSNA) was directly evaluated by microneurography. Forearm blood flow was evaluated by venous occlusion plethysmography. Baseline MSNA were significantly greater in HF patients (33 plus or minus 3 vs. 20 plus or minus 2 bursts/min, P = 0.001). Forearm vascular conductance (FVC) was not different between the groups. During hypoxia, the increase in MSNA was significantly greater in HF patients than in normal controls (9.0 plus or minus 1.6 vs. 0.8 plus or minus 2.0 bursts/min, P = 0.001). The increase in FVC was significantly lower in HF patients (0.00 plus or minus 0.10 vs. 0.76 plus or minus 0.25 units, P = 0.001). During hypercapnia, MSNA responses were significantly greater in HF patients than in normal controls (13.9 plus or minus 3.2 vs. 2.1 plus or minus 1.9 bursts/min, P = 0.001). FVC responses were significantly lower in HF patients (-0.29 plus or minus 0.10 vs. 0.37 plus or minus 0.18 units, P = 0.001). In conclusion, muscle vasodilatation during peripheral and central chemoreceptor stimulation is blunted in HF patients. This vascular response seems to be explained, at least in part, by the exaggerated MSNA responses during hypoxia and hypercapnia.</description><identifier>ISSN: 0363-6143</identifier><identifier>EISSN: 1522-1563</identifier><language>eng</language><ispartof>American Journal of Physiology: Cell Physiology, 2007-07, Vol.293 (1), p.H846-H852</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Di Vanna, Andrea</creatorcontrib><creatorcontrib>Braga, Ana Maria FW</creatorcontrib><creatorcontrib>Laterza, Mateus C</creatorcontrib><creatorcontrib>Ueno, Linda M</creatorcontrib><creatorcontrib>Rondon, Maria Urbana PB</creatorcontrib><creatorcontrib>Barretto, Antonio CP</creatorcontrib><creatorcontrib>Middlekauff, Holly R</creatorcontrib><creatorcontrib>Negrao, Carlos E</creatorcontrib><title>Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure</title><title>American Journal of Physiology: Cell Physiology</title><description>Chemoreflex control of sympathetic nerve activity is exaggerated in heart failure (HF) patients. However, the vascular implications of the augmented sympathetic activity during chemoreceptor activation in patients with HF are unknown. We tested the hypothesis that the muscle blood flow responses during peripheral and central chemoreflex stimulation would be blunted in patients with HF. Sixteen patients with HF (49 plus or minus 3 years old, Functional Class II-III, New York Heart Association) and 11 age-paired normal controls were studied. The peripheral chemoreflex control was evaluated by inhalation of 10% O sub(2) and 90% N sub(2) for 3 min. The central chemoreflex control was evaluated by inhalation of 7% CO sub(2) and 93% O sub(2) for 3 min. Muscle sympathetic nerve activity (MSNA) was directly evaluated by microneurography. Forearm blood flow was evaluated by venous occlusion plethysmography. Baseline MSNA were significantly greater in HF patients (33 plus or minus 3 vs. 20 plus or minus 2 bursts/min, P = 0.001). Forearm vascular conductance (FVC) was not different between the groups. During hypoxia, the increase in MSNA was significantly greater in HF patients than in normal controls (9.0 plus or minus 1.6 vs. 0.8 plus or minus 2.0 bursts/min, P = 0.001). The increase in FVC was significantly lower in HF patients (0.00 plus or minus 0.10 vs. 0.76 plus or minus 0.25 units, P = 0.001). During hypercapnia, MSNA responses were significantly greater in HF patients than in normal controls (13.9 plus or minus 3.2 vs. 2.1 plus or minus 1.9 bursts/min, P = 0.001). FVC responses were significantly lower in HF patients (-0.29 plus or minus 0.10 vs. 0.37 plus or minus 0.18 units, P = 0.001). In conclusion, muscle vasodilatation during peripheral and central chemoreceptor stimulation is blunted in HF patients. This vascular response seems to be explained, at least in part, by the exaggerated MSNA responses during hypoxia and hypercapnia.</description><issn>0363-6143</issn><issn>1522-1563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNyk0KwjAQQOEgCtafO8zKXaFpbKVbRfEAbqWEdmojaVIzE72-gh7A1XuLbyISWeR5KotSTUWSqVKlpdyquVgQ3bMs2-ZllYjr3kbH2MIQqbEIT02-NVazZuMdtDEYd4Omx8EHbHBkH4DYDNF-gXEwfg4dE7wM99CjDgydNjYGXIlZpy3h-tel2JyOl8M5HYN_RCSuB0MNWqsd-ki1rHZKqmKn_oZv2n5J1g</recordid><startdate>20070701</startdate><enddate>20070701</enddate><creator>Di Vanna, Andrea</creator><creator>Braga, Ana Maria FW</creator><creator>Laterza, Mateus C</creator><creator>Ueno, Linda M</creator><creator>Rondon, Maria Urbana PB</creator><creator>Barretto, Antonio CP</creator><creator>Middlekauff, Holly R</creator><creator>Negrao, Carlos E</creator><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20070701</creationdate><title>Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure</title><author>Di Vanna, Andrea ; Braga, Ana Maria FW ; Laterza, Mateus C ; Ueno, Linda M ; Rondon, Maria Urbana PB ; Barretto, Antonio CP ; Middlekauff, Holly R ; Negrao, Carlos E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_197313573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Di Vanna, Andrea</creatorcontrib><creatorcontrib>Braga, Ana Maria FW</creatorcontrib><creatorcontrib>Laterza, Mateus C</creatorcontrib><creatorcontrib>Ueno, Linda M</creatorcontrib><creatorcontrib>Rondon, Maria Urbana PB</creatorcontrib><creatorcontrib>Barretto, Antonio CP</creatorcontrib><creatorcontrib>Middlekauff, Holly R</creatorcontrib><creatorcontrib>Negrao, Carlos E</creatorcontrib><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>American Journal of Physiology: Cell Physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Di Vanna, Andrea</au><au>Braga, Ana Maria FW</au><au>Laterza, Mateus C</au><au>Ueno, Linda M</au><au>Rondon, Maria Urbana PB</au><au>Barretto, Antonio CP</au><au>Middlekauff, Holly R</au><au>Negrao, Carlos E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure</atitle><jtitle>American Journal of Physiology: Cell Physiology</jtitle><date>2007-07-01</date><risdate>2007</risdate><volume>293</volume><issue>1</issue><spage>H846</spage><epage>H852</epage><pages>H846-H852</pages><issn>0363-6143</issn><eissn>1522-1563</eissn><abstract>Chemoreflex control of sympathetic nerve activity is exaggerated in heart failure (HF) patients. However, the vascular implications of the augmented sympathetic activity during chemoreceptor activation in patients with HF are unknown. We tested the hypothesis that the muscle blood flow responses during peripheral and central chemoreflex stimulation would be blunted in patients with HF. Sixteen patients with HF (49 plus or minus 3 years old, Functional Class II-III, New York Heart Association) and 11 age-paired normal controls were studied. The peripheral chemoreflex control was evaluated by inhalation of 10% O sub(2) and 90% N sub(2) for 3 min. The central chemoreflex control was evaluated by inhalation of 7% CO sub(2) and 93% O sub(2) for 3 min. Muscle sympathetic nerve activity (MSNA) was directly evaluated by microneurography. Forearm blood flow was evaluated by venous occlusion plethysmography. Baseline MSNA were significantly greater in HF patients (33 plus or minus 3 vs. 20 plus or minus 2 bursts/min, P = 0.001). Forearm vascular conductance (FVC) was not different between the groups. During hypoxia, the increase in MSNA was significantly greater in HF patients than in normal controls (9.0 plus or minus 1.6 vs. 0.8 plus or minus 2.0 bursts/min, P = 0.001). The increase in FVC was significantly lower in HF patients (0.00 plus or minus 0.10 vs. 0.76 plus or minus 0.25 units, P = 0.001). During hypercapnia, MSNA responses were significantly greater in HF patients than in normal controls (13.9 plus or minus 3.2 vs. 2.1 plus or minus 1.9 bursts/min, P = 0.001). FVC responses were significantly lower in HF patients (-0.29 plus or minus 0.10 vs. 0.37 plus or minus 0.18 units, P = 0.001). In conclusion, muscle vasodilatation during peripheral and central chemoreceptor stimulation is blunted in HF patients. This vascular response seems to be explained, at least in part, by the exaggerated MSNA responses during hypoxia and hypercapnia.</abstract></addata></record>
fulltext fulltext
identifier ISSN: 0363-6143
ispartof American Journal of Physiology: Cell Physiology, 2007-07, Vol.293 (1), p.H846-H852
issn 0363-6143
1522-1563
language eng
recordid cdi_proquest_miscellaneous_19731357
source American Physiological Society; EZB-FREE-00999 freely available EZB journals
title Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T06%3A01%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blunted%20muscle%20vasodilatation%20during%20chemoreceptor%20stimulation%20in%20patients%20with%20heart%20failure&rft.jtitle=American%20Journal%20of%20Physiology:%20Cell%20Physiology&rft.au=Di%20Vanna,%20Andrea&rft.date=2007-07-01&rft.volume=293&rft.issue=1&rft.spage=H846&rft.epage=H852&rft.pages=H846-H852&rft.issn=0363-6143&rft.eissn=1522-1563&rft_id=info:doi/&rft_dat=%3Cproquest%3E19731357%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19731357&rft_id=info:pmid/&rfr_iscdi=true